COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Anthracyclines inhibit -1 programmed ribosomal frameshifting and restrict HCoV-OC43 infection
Scheller, D., Islam, K., Lindgren, L., Arnberg, N., Johansson, J.
10.64898/2026.03.08.709729 — Posted: 2026-03-10
One and Done: A safe, adaptable single-cycle SARS-CoV-2 vaccine platform blocks XBB.1.5 infection and transmission
Schoen, J., Halwe, N. J., Britzke, T., Breithaupt, A., Ulrich, L., Kochmann, J., Corleis, B., Kipfer, E. T., Klimkait, T., Hoffmann, D., Otte, F., Beer, M., Hauser, D.
10.64898/2026.03.09.709481 — Posted: 2026-03-10
A Universal, AI-based Design Framework for Efficient Manufacturing of mRNA Therapeutics
Liao, K.-C., Maccari, G., Ciano, G., Huber, R., von der Haar, T., Tham, C.-Y., Ting Xun Ong, N., Florez de Sessions, P., Yih Saw, T., Wei Lim, T., Martin, C., Dickman, M., Kis, Z., Makatsoris, H., van Asbeck, A., Wan, Y., Medini, D.
10.64898/2026.03.09.710039 — Posted: 2026-03-10
The serum from critical COVID-19 patients induces proteomic changes in olfactory neuroepithelial cells that resemble post-covid neurological complications
Beltran-Camacho, L., Bhosale, S., Hidalgo-Figueroa, M., Delgado-Sequera, A., Sanchez-Morillo, D., Perez-Revuelta, J., Romero Lopez-Alberca, C., Larsen, M., Moreno-Luna, R., Berrocoso, E., Duran-Ruiz, M. C.
10.64898/2026.03.09.710460 — Posted: 2026-03-10
Molecular Characterization of SARS-CoV-2 N Protein Interfaces: Implications for Oligomerization, RNA Binding, and Phase Separation
Bairy, S. G., Prasad, T. K., Saravana Kumar, Y., Ganavi, B., S, S., S, S., Baskaran, S. P., Sounderrajan, V., Parthasarathy, K., Kamariah, N.
10.64898/2026.03.06.710084 — Posted: 2026-03-06
A macrocyclic peptide-based fusion inhibitor targeting SARS-CoV-2 Spike S2 subunit
Ohashi, H., Kawamura, T., Ohuchi, M., Kurasaki, H., Iwata-Yoshikawa, N., Hirata, Y., Moriyama, S., Shionoya, K., Nagatomo, K., Nagasawa, T., Yamamoto, J., Sudo, K., Nakamura, N., Matsui, K., Ogawa, H., Yoshida, K., Shimada, Y., Maruyama, T., Higuchi, T., Ito, S., Takahashi, Y., Kawamura, N., Reid, P. C., Murakami, M., Suzuki, T., Nagata, N., Kitamura, H., Watashi, K.
10.64898/2026.03.04.703990 — Posted: 2026-03-05
Investigating the use of human COVID-19 rapid assays to detect antibody and antigen in domesticated dogs (Canis lupus familiaris) and cats (Felis catus)
Cybulska, L. C., Hamer, S. A., Teasdale, C., Johnson, G., Hamer, G., Grassman, J.
10.64898/2026.03.04.709710 — Posted: 2026-03-05
Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS CoV-2
Auge-Stock, M., Okwu, D. G., More, A., Doralt, A., Bikangui, R., Boussoukou, I. P. M., Eberhardt, K. A., Sandkuhl, M., Zoleko Manego, R., Mombo Ngoma, G., McCall, M., Breloer, M., Esen, M., Addo, M., Lell, B., Veletzky, L., Adamou, R., Mackroth, M. S.
10.64898/2026.03.02.708985 — Posted: 2026-03-04
Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
Jaiswal, D., Altomare, C. G., Adelsberg, D. C., Sapse, I. A., Krammer, F., Simon, V., Ellebedy, A. H., Bajic, G.
10.64898/2026.03.03.709398 — Posted: 2026-03-04
Fluorinated RNA origami enables serum-stable nanodevices for sensing and targeting
Kristoffersen, E. L., Zwergius, N. H., Sampedro Vallina, N., Stange, A. D., Desdorf, L. M., Thomsen, S., Birkedal, V., Glück, N., Civit, L., Geary, C., Kjems, J., Valero, J., Andersen, E. S.
10.64898/2026.03.04.709525 — Posted: 2026-03-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).